Johnson & Johnson vs Thermo Fisher Scientific Inc — Stock Comparison
Johnson & Johnson (JNJ) and Thermo Fisher Scientific Inc (TMO) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Thermo Fisher Scientific Inc narrowly edges Johnson & Johnson on Q·Score (7.5 vs 7.1 out of 10), led by Sentiment (8.1 vs 6.9) and Health (7.6 vs 6.5). Johnson & Johnson scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for TMO (+29.0%) than for JNJ (+10.7%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Consensus analyst target of $599.19 is 29% above current price.
Analyst Consensus
Fundamentals
Frequently Asked Questions
JNJ vs TMO: which stock scores better overall?
Based on Q·Score, Thermo Fisher Scientific Inc (TMO) scores 7.5/10 versus Johnson & Johnson (JNJ) at 7.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: JNJ or TMO?
Thermo Fisher Scientific Inc (TMO) scores higher on Growth (6.1/10 vs 5.1/10). Johnson & Johnson reports revenue growth (9.9% YoY) while Thermo Fisher Scientific Inc reports (6.2% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is JNJ or TMO more attractively valued?
Thermo Fisher Scientific Inc (TMO) scores higher on Valuation (8.2/10 vs 7.3/10). JNJ trades at 18.0× P/E versus TMO at 17.1×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about JNJ vs TMO?
There are 23 analysts covering JNJ with a consensus price target of $252.87, and 26 analysts covering TMO with a consensus target of $599.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: JNJ or TMO?
Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 7.7/10). Net profit margin: JNJ at 21.8%, TMO at 15.2%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: JNJ or TMO?
Thermo Fisher Scientific Inc (TMO) scores higher on Financial Health (7.6/10 vs 6.5/10). Market beta: JNJ at 0.26, TMO at 0.87. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of JNJ and TMO?
Johnson & Johnson (JNJ) has a market capitalisation of $549.8B, while Thermo Fisher Scientific Inc (TMO) has a market cap of $172.7B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do JNJ or TMO pay dividends?
JNJ pays a dividend yield of 2.35%, while TMO pays a dividend yield of 0.40%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →